FindTrial
Sign In

Investigation of treatment of algodystrophy by guanethidine blockade

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN24808507
Enrollment
Unknown
Registered
2003-01-07
Start date
1999-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reflex sympathetic dystrophy Musculoskeletal Diseases Osteopathies and chondropathies

Interventions

Intravenous regional (Biers) block to the affected arm using either: 1. 30 ml normal saline, or 2. 15 mg guanethidine in 30 ml 0.5% pritocaine

Sponsors

Arthritis Research Campaign (ARC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Closed, unilateral fracture of the distal radius

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026